Self-silencing adenovirus enables precise infectious titration of recombinant adeno-associated viral vectors
Robust and accurate quantification of recombinant adeno-associated virus (rAAV) vectors’ infectivity is essential for pre-clinical and clinical development of AAV gene therapy programs. The industry standard method for rAAV titration is the 50% tissue culture infectious dose (TCID50) assay using HeL...
Saved in:
| Main Authors: | Chloé Fustinoni, Xiang Liu, Zhi Chen, Ryan Cawood, Weimin Valenti, Maria I. Patrício, Weiheng Su |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Molecular Therapy: Methods & Clinical Development |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050125000877 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pilot-scale process development for recombinant adeno-associated virus (rAAV) production based on high-density Sf9 cell culture
by: Xinran Li, et al.
Published: (2024-11-01) -
Recombinant adeno-associated virus 2-mediated miRNA-199 suppression vector alleviates dextran sulfate sodium-induced ulcerative colitis in mice
by: Wang Shanshan, et al.
Published: (2025-07-01) -
Identification of SLC35A1 as an essential host factor for the transduction of multi-serotype recombinant adeno-associated virus (AAV) vectors
by: Xiujuan Zhang, et al.
Published: (2025-01-01) -
AAV induces hepatic necroptosis and carcinoma in diabetic and obese mice dependent on Pebp1 pathway
by: Yalan Cheng, et al.
Published: (2023-06-01) -
Three-dimensional linkage analysis with digital PCR for genome integrity and identity of recombinant adeno-associated virus
by: Tam Duong, et al.
Published: (2025-01-01)